QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-is-unitedhealth-stock-trading-higher-friday

UnitedHealth shares jump after Buffett and Burry invest, despite earnings miss and DOJ settlement in $3.3 billion Amedisys deal.

Core News & Articles

https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20250814-1479497/1479497_amed4.pdf

 unitedhealth-group-climbs-117-after-hours-following-221-quarterly-dividend-authorization

UnitedHealth stock rose after-hours on a new dividend announcement but remains down over 50% from last year.

 whats-going-on-with-unitedhealth-stock-monday

UnitedHealth will sell 164 healthcare facilities in a DOJ settlement over its Amedisys deal while missing Q2 earnings and reaff...

 unitedhealth-faces-large-outpatient-divestiture-to-resolve-antitrust-suit-related-to-amedisys-deal

UnitedHealth will divest 164 healthcare locations and Amedisys will pay a $1.1 million penalty under a DOJ settlement resolving...

Core News & Articles

- SEC Filing

Core News & Articles

https://www.justice.gov/opa/pr/justice-department-requires-broad-divestitures-resolve-challenge-unitedhealths-acquisition Decre...

 home-health-braces-for-potential-1-billion-cut-in-medicare-payments

The Centers for Medicare & Medicaid Services (CMS) released a proposed rule on Monday outlining changes to how Medicare pay...

 amedisys-q1-adj-eps-125-beats-109-estimate-sales-59478m-miss-59622m-estimate

Amedisys (NASDAQ:AMED) reported quarterly earnings of $1.25 per share which beat the analyst consensus estimate of $1.09 by 14....

 rbc-capital-reiterates-outperform-on-amedisys-maintains-100-price-target

RBC Capital analyst Ben Hendrix reiterates Amedisys (NASDAQ:AMED) with a Outperform and maintains $100 price target.

 stephens--co-reiterates-equal-weight-on-amedisys-maintains-101-price-target

Stephens & Co. analyst Scott Fidel reiterates Amedisys (NASDAQ:AMED) with a Equal-Weight and maintains $101 price target.

 amedisys-q4-2024-adj-eps-096-misses-105-estimate-sales-598052m-miss-598576m-estimate

Amedisys (NASDAQ:AMED) reported quarterly earnings of $0.96 per share which missed the analyst consensus estimate of $1.05 by 8...

 stephens--co-reiterates-equal-weight-on-amedisys-maintains-101-price-target

Stephens & Co. analyst Raj Kumar reiterates Amedisys (NASDAQ:AMED) with a Equal-Weight and maintains $101 price target.

 unitedhealth-group-q4-earnings-preview-first-report-since-insurance-ceos-murder-comes-with-questions-on-companys-future

UnitedHealth shares a quarterly report for the first time since the death of insurance unit leader Brian Thompson. A look at th...

 amedisys-and-unitedhealth-extend-merger-deadline---whats-going-on

Amedisys and UnitedHealth extend their $3.3B merger deadline to 2025, amid DOJ scrutiny over competition concerns in the home h...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION